Platelet Function Test Market Projected Growth to USD 2,607.5 Million with 6.3% CAGR, Driven by Technological Advancements

January 29, 2025 6:00 AM

The global Platelet Function Test Market is set to experience robust growth from 2025 to 2035, with its market size projected to grow from USD 1,375.8 million in 2025 to USD 2,607.5 million by 2035 at a CAGR of 6.3%. This growth is attributed to the increasing prevalence of platelet-related disorders, rising adoption of diagnostic technologies, and growing demand for personalized medicine.The healthcare industry's focus on improving diagnostic...

Read more

Compassion Center, Coalition for Patients' Rights, and Integrative Providers Association Urge Senate to Confirm RFK Jr. as Secretary of Health and Human Services

January 29, 2025 4:20 AM

Compassion Center, the Coalition for Patients' Rights, and the Integrative Providers Association stand together in strong support of Robert F. Kennedy Jr.'s confirmation as Secretary of Health and Human Services (HHS). We urge the Senate to move forward with his confirmation, recognizing the urgent need for leadership that prioritizes patient rights, healthcare accessibility, and holistic, science-backed solutions.For decades, Secretary Kennedy...

Read more

Hera BioLabs Increases Scientific Transparency and Engagement With Bioz Technology

January 29, 2025 4:00 AM

Bioz, Inc., a cutting-edge innovator in AI-driven product engagement and citation analytics, is excited to announce its successful integration of Bioz Badges on the website of Hera BioLabs, a leading provider of high-quality gene-editing reagents for the established Cas-CLOVER™ and piggyBac® Transposon systems. This integration has not only significantly boosted product visibility, engagement, and sales conversion but has also helped Hera...

Read more

Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay

January 29, 2025 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted to announce new, successful results for the Company's dual circulating tumour DNA (ctDNA) and CTC-DNA workflow using, for the first time, an end-to-end Illumina solution for analysis.Over the last six months, ANGLE has overcome technical issues to...

Read more

Historic Launch: Universal Mayan Keyboard Now Available for Microsoft Windows

January 28, 2025 6:40 PM

The Mayan Languages Preservation and Digitization Project, supported by MasterWord Services, announces the release of its first Universal Mayan Keyboard for Microsoft Windows. This new tool represents a pivotal step toward advancing digital accessibility for more than seven million Mayan language speakers, building on earlier Google Android offerings and expanding the ways Mayan speakers can write and communicate online.Ingrid Pacay, project...

Read more

Dermata Expands Patent Portfolio with Issuance of New U.S. Patent for Next-Generation Acne Treatment

January 28, 2025 4:05 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced issuance by the United States Patent and Trademark Office of a new patent for its XYNGARI™ product candidate for the treatment of acne. The issued patent, entitled "Compositions and methods for the treatment of skin conditions" (U.S....

Read more

Paragon Health IT Announces Divestiture of Paragon Consulting Partners and Rebranding as Strings

January 28, 2025 12:00 PM

Paragon Health IT announced a strategic reorganization effective January 1, 2025. As part of this reorganization, Paragon Health IT will divest Paragon Consulting Partners, which will become a separate entity. Barbara Smith will lead Paragon Consulting Partners as its Managing Partner. Smith stated, "We are excited about this new chapter and the opportunities it brings. Our focus will remain on delivering exceptional consulting services to our...

Read more

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

January 28, 2025 11:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that, on January 27, 2025, its wholly owned subsidiary, CosmoFarm S.A. (the "Issuer" or "CosmoFarm"), entered into an...

Read more

Glidewell to Host Nine Symposia in 2025

January 28, 2025 11:00 AM

Glidewell has announced its 2025 symposia schedule. With more than 50 years supporting innovation in restorative dentistry, the dental laboratory is in a unique position to understand and respond to the needs of dentists - including the need for continuing education opportunities that address the latest technological advancements.The first Glidewell Symposium took place in 2017. Now, presented at the state-of-the-art Glidewell Clinical Education...

Read more

AGFA HealthCare at HIMSS 2025: Revolutionizing Enterprise Imaging with Innovation and Work-Life Balance

January 28, 2025 10:20 AM

As the demand for medical imaging surges, IT departments face growing pressures to keep up the pace and adopt the latest innovations - ensuring best-in-class imaging management and data security for their overworked imaging teams. This is why, at this year's HIMSS Global Health Conference and Exhibition, March 3-6, 2025 in Las Vegas, AGFA HealthCare will showcase groundbreaking innovations designed to drive business growth and clinical...

Read more

AcceleDev Appoints Dr. Fu-An Kang as Vice President of Chemistry Research & Development

January 28, 2025 10:00 AM

AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process development, is pleased to announce the appointment of Dr. Fu-An Kang as its new Vice President of Chemistry Research & Development. With over 25 years of extensive management and leadership experience in pharma/biotech R&D, process development, cGMP manufacturing and supply chain management, Dr. Kang is set...

Read more

DirectTrust(R) Seeks Nominations for New Board Directors

January 28, 2025 9:05 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, today announced a call for nominations for new Board Directors. A volunteer position, DirectTrust's Board of Directors supports the work of the organization with mission-based leadership and strategic governance. Nominations will be accepted through March 14,...

Read more

Ankle & Foot Centers of America Relocates Canton Office to Enhance Patient Care

January 28, 2025 9:01 AM

Ankle & Foot Centers of America, one of the nation's top podiatry groups for three decades, is pleased to announce the recent relocation of its Canton, Georgia, office to a new, upgraded facility on Oakside Lane. The move highlights the company's ongoing commitment to offering high-quality and accessible podiatric care, while aligning with its broader strategy of modernizing its facilities to meet the needs of patients and growing...

Read more

UTMD Reports Year 2024 and Fourth Quarter Financial Performance

January 28, 2025 9:00 AM

With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) concluded a year of contraction. UTMD's stock price declined 27%, more than twice the EPS decline, which allowed the Company an opportunity to repurchase more than 8% of its shares in the open market.Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK...

Read more

Resyca Receives Medical Device Regulation Certificate From TÜV SÜD

January 28, 2025 9:00 AM

Resyca BV, a pioneering leader in the development and manufacturing of advanced inhalation drug delivery devices, proudly announces successful certification under the European Medical Device Regulation (MDR, Regulation (EU) 2017/745) by notified body TÜV SÜD Product Service. This certification marks a significant milestone, demonstrating that all Resyca's design, development, and manufacturing processes comply fully with stringent MDR...

Read more

Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings

January 28, 2025 8:00 AM

Orgenesis Inc. (OTCQX:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies (CGT) in order to improve access and outcomes in healthcare, today announced that it has concluded an agreement for an equity line of credit of up to $5 million from Williamsburg Venture Holdings, LLC, a Nevada-based family office.Under the terms of the agreement, Orgenesis will receive $750,000...

Read more

Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses

January 28, 2025 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or Telomir, a leader in age-reversal science, today announced groundbreaking results from its recent preclinical studies conducted in human cell lines. These studies demonstrated the ability of Telomir-1 to fully reverse copper-induced elevation of Reactive Oxygen Species (ROS) and provide robust cellular protection against copper toxicity."The results of our studies demonstrate the exceptional...

Read more

Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation

January 28, 2025 7:05 AM

CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) and Johns Hopkins University have successfully submitted our proposal for a NIH Grant that will utilize CTT's patented technology as a smoking cessation product. This grant will allow for clinical trials to be conducted and up to $15 million given to cover these trials. The NIH will begin the review process of this proposal in April 2025 and will notify Johns Hopkins University and CTT Pharma of the...

Read more

Russia’s Viscosupplementation Market to Witness Robust Growth, Estimated to Reach USD 97.9 Million by 2035 rise at a CAGR of 5.8% | Future Market Insights, Inc.

January 28, 2025 4:30 AM

The viscosupplementation market in Russia is poised for significant growth in the coming decade, with sales estimated to climb from USD 55.7 million in 2025 to an impressive USD 97.9 million by 2035, according to market projections. This represents a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2025 to 2035.The upward trajectory of viscosupplementation sales in Russia reflects an increased demand for non-invasive...

Read more

Year-End Report 2024

January 28, 2025 2:00 AM

GOTHENBURG, SE / ACCESSWIRE / January 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Fourth quarter 2024 (October 1 - December 31)• Net sales amounted to SEK 227.6 million (155.7), corresponding to growth of 46 percent in SEK and 45 percent in local currencies.• Organic growth accounted for 44 percent and acquired growth for 1 percent. All business areas delivered underlying organic growth adjusted for currency effects: Thoracic...

Read more